Results
2
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
2 companies
Saniona
Market Cap: SEK 1.2b
A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 8.59
7D
-6.4%
1Y
159.1%
BioGaia
Market Cap: SEK 10.0b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 98.65
7D
-8.1%
1Y
-23.5%